The inventory opened at Rs 3800 and touched an intraday excessive and low of Rs 4057.1 and Rs 3650, respectively, within the session to date. The inventory of AstraZeneca Pharma India Ltd. quoted a 52-week high of Rs 4970 and a 52-week low of Rs 1888.
Whole market cap of the AstraZeneca Pharma India Ltd. stood at Rs 9972.5 crore on the time of penning this report.
Late-stage research of AstraZeneca’s Covid-19 vaccine candidate are on momentary maintain whereas the corporate investigates whether or not a affected person suffered a critical aspect impact or if the sickness had nothing to do with the shot.
Key Financials
The corporate reported consolidated gross sales of Rs 193.58 crore for the quarter ended 30-Jun-2020, down 0.68 per cent from earlier quarter’s Rs 194.9 crore and down 5.37 per cent from the year-ago quarter’s Rs 204.56 crore.
The web revenue for up to date quarter stood at Rs 18.63 crore, down 13.39 per cent from the corresponding quarter final 12 months.
Shareholding sample
As of 30-Jun-2020, DIIs held 3.21 per cent stake within the agency, whereas foreign institutional investors held 1.19 per cent.
Valuation ratio
In response to BSE information, the inventory traded at a P/E a number of of 143.84 and a price-to-book ratio of 27.36. The next P/E ratio exhibits buyers are prepared to pay the next worth due to higher future development expectations. Worth-to-book worth signifies the inherent worth of an organization and is the measure of the worth that buyers are able to pay even for no development within the enterprise.
AstraZeneca Pharma India Ltd. belongs to the Pharma – MNC trade.
from WordPress https://ift.tt/2R8cfeV
via IFTTT
No comments:
Post a Comment